Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-05-22
1997-02-11
Ivy, C. Warren
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546141, C07D21724, A61K 3147
Patent
active
056021453
ABSTRACT:
This invention relates to compounds of the formula: ##STR1## which are effective for inhibiting platelet aggregation, pharmaceutical compositions for effecting such activity, and a method for inhibiting platelet aggregation.
REFERENCES:
patent: 5116985 (1992-05-01), Takeshita
patent: 5260316 (1993-11-01), Van Duzer et al.
patent: 5338851 (1994-08-01), Huff et al.
Banner, Perspect. Med. Chem., pp. 27-43, 1993.
Shuman, J. Med. Chem., vol. 36, pp. 314-319, 1993.
Thrombosis and Haemostasis, vol. 70(1), pp. 94-98 (1993), Topol et al.
Coronary Artery Disease, vol. 3, No. 11, pp. 1016-1029 (1992), Coller.
J. of Pharmacology and Experimental Therapeutics, vol. 270, No. 2, pp. 614-621 (1994), Nichols.
TIPS, vol. 13, pp. 413-417 (1992), Nichols et al.
Chemical Abstracts, vol. 93, No. 5, p. 910 (1980).
Chemical Abstracts, vol. 76, No. 1, pp. 3667-3668 (1972).
Ivy C. Warren
Lentz Edward T.
M. Mach D. Margaret
McCarthy Mary
SmithKline Beecham Corporation
LandOfFree
Bicyclic fibrinogen antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bicyclic fibrinogen antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bicyclic fibrinogen antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-342421